CRISPR opens the door to targeted therapy against glioblastoma (Review)
International Journal of Oncology · 12.11.2026 · 69 (6) · 1-12
DOI: 10.3892/ijo.2026.5957 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Oncology, online erschienen am 12.11.2026. Verfasst von Chunzhi Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Tianjin Hospital, Tianjin University, Tianjin 300211, P.R. China. Hauptthemen laut MEDLINE: Glioblastoma, CRISPR-Cas Systems, Brain Neoplasms, Molecular Targeted Therapy.
Abstract (Originalsprache)
The progression in molecular understanding of glioblastoma (GBM) enables the identification of key therapeutic targets, allowing the advances of targeted therapy in GBM. However, to date, most clinical trial results have been disappointing. The clustered regularly interspaced short palindromic repeats (CRISPR) system is a revolutionary genome‑editing tool that has the potential to improve basic research and therapy for GBM. In the present review, the current status and challenges of targeted therapy in GBM are examined. As a potential approach to address the challenges, the development process and application scope of CRISPR are investigated. Furthermore, the application of CRISPR in the study of GBM is explored, mainly by conducting CRISPR screens and employing CRISPR to target genes associated with the malignant phenotype of GBM. Finally, delivery of CRISPR/CRISPR‑associated protein 9 (Cas9) for the treatment of GBM is briefly reviewed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Tianjin Hospital, Tianjin University, Tianjin 300211, P.R. China.
- State Key Laboratory of Synthetic Biology, Frontiers Science Center for Synthetic Biology, Key Laboratory of Systems Bioengineering, Ministry of Education (MOE), School of Synthetic Biology and Biomanufacturing, Tianjin…
Zitieren
APA
Zhang, C., Zhang, Y., Song, N., Zhang, L., Zhao, Y., & Yao, C. (2026). CRISPR opens the door to targeted therapy against glioblastoma (Review). International Journal of Oncology, 69(6), 1-12. https://doi.org/10.3892/ijo.2026.5957
Vancouver
Zhang C, Zhang Y, Song N, Zhang L, Zhao Y, Yao C. CRISPR opens the door to targeted therapy against glioblastoma (Review). International Journal of Oncology. 2026;69(6):1-12. doi:10.3892/ijo.2026.5957
BibTeX
@article{Zhang2026,
author = {Zhang, Chunzhi and Zhang, Yixin and Song, Nachuan and Zhang, Le and Zhao, Yunying and Yao, Chi},
title = {CRISPR opens the door to targeted therapy against glioblastoma (Review)},
journal = {International Journal of Oncology},
year = {2026},
volume = {69},
number = {6},
pages = {1--12},
doi = {10.3892/ijo.2026.5957}
}
EUVIMED